TXMD stock forecast
Our latest prediction for TherapeuticsMD Inc's stock price was made on the Dec. 14, 2022 when the stock price was at 7.00$.
In the short term (2weeks), TXMD's stock price should underperform the market by -4.09%. During that period the price should oscillate between -14.53% and +8.47%.
In the medium term (3months), TXMD's stock price should underperform the market by -13.17%. During that period the price should oscillate between -31.18% and +22.65%.
Get email alertsCreate a solid portfolio with TXMD
About TherapeuticsMD Inc
therapeuticsmd, inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. we create products to address the unique changes and challenges women experience through every stage of their lives. with momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. this includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitamedmd® and bocagreenmd® brands. see our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines
At the moment the company generates 185M USD in revenues.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is 0.03$
Three months stock forecastDec. 14, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
185M | 37.30% | -101M | -54.43% | -119M | - | - | - | 9M | 0.03 | - | - | - |